Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For IEP
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
17%
Leverage & Liquidity Weak
17%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -10.34 2.31 2.58
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 2410.66 384.06 15.30
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -14.10 8.28 9.63
Cash -18.71 11.73 14.43
Capex 35.98 -0.16 -0.25
Free Cash Flow 2256.61 -0.74 0.03
Revenue -27.36 5.22 7.18
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -77.92 0.04 0.16
Operating Margin -47.11 -0.05 0.09
ROA 71.72 < 0.005 < 0.005
ROE 69.58 -0.01 -0.03
ROIC -44.16 -0.01 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of IEP is permitted for members.
5 Growth
The "Growth Entry" for the Focus of IEP is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of IEP is permitted for members.